About Sudisa Industries Private Limited
Data last updated:
Sudisa Industries Private Limited is a private limited company based in Indore, Madhya Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 01 August 1984 and has been in existence for over 42 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24232MP1984PTC002519. Its GSTIN is 23AAECS3440B1Z0 (Madhya Pradesh).
The company has an authorised share capital of ₹2.5 Cr and a paid-up capital of ₹2.48 Cr. It was formerly known as Sanctus Drugs & Pharmaceuticals Pvt Ltd. It is led by directors including Rahul Jain and Sanjay Jain.
Its last annual general meeting (AGM) was held on 24 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 410 Shalimar Corpororate Centre 8 – B South Tukoganj, Indore, Madhya Pradesh, India – 452001.
As per the financials filed for FY 2025, the company reported a revenue of ₹8.5 Cr, a growth of 106% compared to the previous year. For the same year it recorded a net profit of ₹11.56 Lakh (net margin 1.4%) and EBITDA of ₹80.37 Lakh (EBITDA margin 9.5%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 5% over five years.
As per MCA filings, the company has open charges of ₹5.8 Cr and satisfied charges of ₹7.3 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sanctusdrugs.com.
Company details
Contact details
Sudisa Industries Private Limited's registered office is in Indore, Madhya Pradesh. Its website is sanctusdrugs.com. Its e-mail address is in the company report.
- Email
- Website
- Registered Address410 Shalimar Corpororate Centre 8 – B South Tukoganj, Indore, Madhya Pradesh, India – 452001
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Sudisa Industries Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activities of Sudisa Industries are manufacturing and trade. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and wholesale trading. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | |
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Sudisa Industries Private Limited, buy the company report.
Financials of Sudisa Industries Private Limited
FY 2025 filings availableSudisa Industries Private Limited reported revenue of ₹8.5 Cr (up 106% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 5% over five years, including 106% growth in the latest year. EBITDA rose 208% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹80.37 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹11.56 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.5% | ||||
| Net Profit Margin | 1.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sudisa Industries Private Limited, buy the company report.
Board of directors of Sudisa Industries Private Limited
Sudisa Industries has 4 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rahul Jain | Director | 30 Jun 2020 | 6 Years 4 Months | Current |
| Sanjay Jain Also directs: Vividnexus Trade LLP | Director | 22 Sep 1996 | 30 Years 1 Months | Current |
| Nirmal Mukherjee | Additional Director | 27 Oct 2025 | 1 Years 0 Months | Current |
| Sumit Kumar Agarwal | Additional Director | 27 Oct 2025 | 1 Years 0 Months | Current |
Peer comparison
Sudisa Industries Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Keita Pharma Private Limited | ₹8.51 Cr (FY 2025) | 55.0% | Navi Mumbai, Maharashtra, India | |||
| Sudisa Industries Private Limitedthis company | ₹8.5 Cr (FY 2025) | ₹11.56 Lakh | 1.4% | 106.0% | Indore, Madhya Pradesh, India | |
| Bhawani Acids & Alkalies Private Limited | ₹8.46 Cr (FY 2024) | 17.0% | Uttar Pradesh, India | |||
| S K Solvochem Private Limited | ₹8.45 Cr (FY 2025) | 221.0% | Chandigarh, India |
To see the full peer comparison of Sudisa Industries Private Limited, buy the company report.
Auditor
Sudisa Industries Private Limited is audited by Baldwa & Rathi for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Baldwa & Rathi | FY 2023 | 010540C |
Shareholding
The shareholding of Sudisa Industries Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Sudisa Industries Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 23 Mar 2023 | 100714216 | Hdfc Bank Limited | ₹9.84 Lakh | Satisfied | |
| 18 Mar 2023 | 100704543 | Hdfc Bank Limited | ₹5.8 Cr | Satisfied | |
| 21 Apr 2017 | 100095104 | State Bank of India | ₹8 Lakh | Satisfied | |
| 15 Jan 2002 | 90208983 | State Bank of Indore | ₹10 Lakh | Satisfied | |
| 02 Feb 1995 | 90207577 | State Bank of Indore | ₹7.5 Lakh | Satisfied |
To see the full charge records of Sudisa Industries Private Limited, buy the company report.
Total charge records: 7 View all charges
Legal cases
No court or tribunal cases involving Sudisa Industries Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sudisa Industries Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Sudisa Industries has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AAECS3440B1Z0 | Madhya Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Sudisa Industries Private Limited, buy the company report.
Recent activity
Sudisa Industries Private Limited has 7 board changes on record since 1996: 4 appointments and 3 cessations. The latest: Nirmal Mukherjee was appointed as Additional Director on 27 Oct 2025.
14 earlier events are in the company report.
Frequently asked questions
Sudisa Industries is an active private limited company based in Indore, Madhya Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 01 August 1984 (42+ years old) and is registered under CIN U24232MP1984PTC002519.
Sudisa Industries has 4 current directors:
- Rahul Jain - Director
- Sanjay Jain - Director
- Nirmal Mukherjee - Additional Director
- Sumit Kumar Agarwal - Additional Director
The latest financial statements of Sudisa Industries on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 24 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Sudisa Industries is 23AAECS3440B1Z0, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Sudisa Industries is U24232MP1984PTC002519. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sudisa Industries was incorporated on 01 August 1984, making it 42+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Sudisa Industries by revenue are Keita Pharma Private Limited, Bhawani Acids & Alkalies Private Limited, S K Solvochem Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Nirmal Mukherjee was appointed as Additional Director on 27 Oct 2025. Sumit Kumar Agarwal was appointed as Additional Director on 27 Oct 2025. Rahul Jain ceased to be Director Appointed In Casual Vacancy on 28 Jul 2020. Sudisa Industries has 7 board changes on record in total.
Sudisa Industries can be reached through the website sanctusdrugs.com. Its registered office is in Indore, Madhya Pradesh, India.
The registered office of Sudisa Industries is at 410 Shalimar Corpororate Centre 8 – B South Tukoganj, Indore, Madhya Pradesh, India – 452001.
Sudisa Industries operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
